|
Kadcyla: NICE disappointed by manufacturer's decision
The National Institute for Health and Care Excellence (NICE) is very disappointed that Roche, the manufacturer of Kadcyla (trastuzumab emtansine) has decided not to offer its new treatment at a...
More... |
| All times are GMT -7. The time now is 09:28 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021